Tag: CompleTest™

November 5, 2018

FluroTech Protects Its Technological Advantage with Patent Application

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), is pleased to announce two recently-filed patent applications to which the Company holds exclusive, irrevocable...
October 23, 2018

FluroTech Designs a Cocaine Test for Roadside Impairment Testing

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), a developer of a human saliva-based testing device designed to accurately measure concentrations of ∆9-tetrahydrocannabinol ("THC"), methamphetamines and cocaine, is pleased...
October 19, 2018

FluroTech Applauds Canadian Cannabis Legalization and Provides Operational Update

FluroTech (TSXV:TEST), ("FluroTech" or the "Company") applauds the efforts by the Government of Canada and others to increase public awareness...
September 25, 2018

FluroTech Receives Good Manufacturing Practice Validation of the CompleTest(TM) Cannabinoid Assays for THCa and CBDa

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), is pleased to report that preliminary Good Manufacturing Practice ("GMP") validation testing, done by...
August 29, 2018

FluroTech Accelerates Development of Its Saliva Based Roadside Testing Device and Applauds Canada’s Leadership Role in Ensuring Road Safety

FluroTech (TSXV:TEST), ("FluroTech" or the "Company"), applauds the steps Canada is taking to address issues of impaired driving while under...